Liming Chen

机构：Fujian University of Traditional Chinese Medicine, Guiyang Medical University, People 's Hospital of Jilin Province, Guizhou Cancer Hospital, Tianjin Infectious Diseases Hospital, Affiliated Hospital of Guizhou Medical University, Bristol-Myers Squibb (Italy), First Affiliated Hospital of Bengbu Medical College, Tianjin Medical University, Fujian University of Technology · ORCID：0000-0002-5682-2340

发表论文 276 篇 · 总被引 8284 次 · h-index 44

代表论文

• Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial (2025 · Diabetologia · 被引 24)
• Endothelial AGGF1 promotes retinal angiogenesis by coordinating TNFSF12/FN14 signalling (2025 · Nature Communications · 被引 14)
• Laboratory-simulated marine heatwave enhances physiological damage to mussels exposed to titanium dioxide nanoparticles by disrupting the gut−hepatopancreas axis (2024 · Journal of Hazardous Materials · 被引 10)
• S-nitrosylation of peroxiredoxin 2 exacerbates hyperuricemia-induced renal injury through regulation of mitochondrial homeostasis (2025 · Free Radical Biology and Medicine · 被引 8)
• Periodontal health status and influencing factors among 12- and 15-year-old adolescents: evidence from a cross-sectional study in Guizhou province, China (2019–2020) (2025 · BMC Oral Health · 被引 6)
• Guidelines on primary healthcare for type 2 diabetes in China, 2025 (2025 · Family Medicine and Community Health · 被引 4)